Navigation Links
Inverness Medical Innovations to Participate at Bank of America 2008 Smid Cap Conference on March 26, 2008

WALTHAM, Mass., March 18 /PRNewswire-FirstCall/ -- Inverness Medical Innovations, Inc. (Amex: IMA), a leading manufacturer and marketer of rapid diagnostic products for the consumer and professional markets, announced today that it will attend the upcoming Bank of America 2008 Small and Mid (Smid) Cap Conference being held March 26-27, 2008 at the Four Seasons Hotel in Boston. Ron Zwanziger, Chief Executive Officer, and Jon Russell, Vice President, Finance, will attend. Their presentation is scheduled for Wednesday, March 26, 2008 at 8:50 a.m., and will be made available to the public through a webcast accessible through the company's website at, or directly through the following link: A replay of the webcast will be available approximately 1 hour after the end of the live event through April 11, 2008. During their presentation Mr. Zwanziger and Mr. Russell may discuss and answer questions concerning business and financial developments and trends. Their responses to questions, as well as other matters discussed during the webcast, may contain or constitute information that has not been disclosed previously.

Prior to the conference Inverness will also be posting an updated investor presentation to its website at

By developing new capabilities in near-patient diagnosis, monitoring and health management, Inverness Medical Innovations enables individuals to take charge of improving their health and quality of life. A global leader in rapid point-of-care diagnostics, Inverness' products, as well as its new product development efforts, focus on infectious disease, cardiology, oncology, drugs of abuse and women's health. Inverness is headquartered in Waltham, Massachusetts.

SOURCE Inverness Medical Innovations, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Inverness Medical Innovations Announces Fourth Quarter 2007 Results
2. Inverness Medical Innovations Completes Acquisition of BBI Holdings Plc
3. Correction to Press Release Dated January 31, 2008: Inverness Medical Innovations to Participate at 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference on February 5, 2008
4. Inverness Medical Innovations to Participate at 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference on February 5, 2008
5. Inverness Medical Innovations to Participate at JP Morgan Healthcare Conference on January 8, 2008
6. Inverness Medical Innovations Acquires ParadigmHealth
7. Inverness Medical Innovations Agrees to Acquire ParadigmHealth
8. Inverness Medical Innovations Announces Proposed Public Offering of Common Stock
9. Inverness - Chemogen Establish Exclusive License for TB Antibodies
10. Inverness Medical Innovations Agrees to Acquire Panbio Ltd.
11. BioMS Medical Announces 2007 Year End Results
Post Your Comments:
(Date:6/27/2016)... - BIOREM Inc. (TSX-V: BRM) ("Biorem" or "the Company") announces ... Clean Technology Fund I, LP and Clean Technology Fund ... venture capital funds which together hold approximately 59% of ... as converted basis), that they have entered into an ... in Biorem to TUS Holdings Co. Ltd. ("TUS") ( ...
(Date:6/27/2016)... ... June 27, 2016 , ... Rolf K. ... the faculty of the University of North Carolina Kenan-Flagler Business School ... entrepreneurship at UNC Kenan-Flagler, with a focus on the school’s international efforts, leading ...
(Date:6/24/2016)... ... 2016 , ... While the majority of commercial spectrophotometers and fluorometers use the ... models are higher end machines that use the more unconventional z-dimension of 20mm. ... the bottom of the cuvette holder. , FireflySci has developed several Agilent flow ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT ... Ontario biotechnology company, Propellon Therapeutics ... development and commercialization of a portfolio of first-in-class ... Epigenetic targets such as WDR5 represent an exciting ... significantly in precision medicine for cancer patients. Substantial ...
Breaking Biology Technology:
(Date:6/2/2016)... , June 2, 2016   The Weather Company , ... Watson Ads, an industry-first capability in which consumers will be ... able to ask questions via voice or text and receive ... Marketers have long sought an advertising ... that can be personal, relevant and valuable; and can scale ...
(Date:5/16/2016)... YORK , May 16, 2016   EyeLock ... solutions, today announced the opening of an IoT Center ... to strengthen and expand the development of embedded iris ... an unprecedented level of convenience and security with unmatched ... authenticate one,s identity aside from DNA. EyeLock,s platform uses ...
(Date:4/28/2016)... First quarter 2016:   , Revenues amounted to ... of 2015 The gross margin was 49% (27) ... operating margin was 40% (-13) Earnings per share rose ... was SEK 249.9 M (21.2) , Outlook   ... The operating margin for 2016 is estimated to exceed ...
Breaking Biology News(10 mins):